By Authors

Publications - sorted by Authors

• Schwab J, Haider C, Kopp M, Zrzavy T, Endmayr V, Ricken G, Kubista H, Haider T, Liebscher T, Lübstorf T, Blex C, Serdani-Neuhaus L, Curt A, Cinelli P, Scivoletto G, Fehlings M, May C, Guntermann A, Marcus K, Meisel C, Dirnagl U, Martus P, Prüss H, Popovich P, Lassmann H, Höftberger R (2023) Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord Injury Neurol Neuroimmunol Neuroinfl, 10 (3): e200099

• Krajnc N, Bsteh G, Kasprian G, Zrzavy T, Kornek B, Berger T, Leutmezer F, Rommer P, Lassmann H, Hametner S, Dal-Bianco A (2022) Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis Front Neurol, 13: 928582

• Altmann P, Leithner K, Leutmezer F, Monschein T, Ponleitner M, Stattmann M, Rommer P, Zrzavy T, Zulehner G, Berek K, Berger T, Bsteh G (2021) Sexuality and Multiple Sclerosis: Patient and Doctor Perspectives JSM, 18 (4): 743-749
• Altmann P, Leutmezer F, Leithner K, Monschein T, Ponleitner M, Stattmann M, Rommer P, Zrzavy T, Zulehner G, Berek K, Berger T, Bsteh G (2021) Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis Front Neurol, 12: 618370
• Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Leutmezer F, Rommer P, Wurth S, Zinganell A, Zrzavy T, Deisenhammer F, Berger T (2021) Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis Eur J Neurol, 28 (6): 2037-2045
• Zrzavy T, Daniels E, Stuka N, Weber D, Winkelmann A, Rauschka H, Hecker M, Aboulenein-Djamshidian F, Meister S, Leutmezer F, Berger T, Bsteh G, Zettl UK, Rommer P (2021) Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis Therapeutic Advances in Chronic Disease, 12: 204062232110243
• Ricken G, Zrzavy T, Macher S, Altmann P, Troger J, Falk K, Kiefer A, Fichtenbaum A, Mitulovic G, Kubista H, Wandinger K, Rommer P, Bartsch T, Berger T, Weber J, Leypoldt F, Höftberger R (2021) Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings Neurol Neuroimmunol Neuroinfl, 8 (4): e1019
• Macher S, Milenkovic I, Zrzavy T, Höftberger R, Seidel S, Berger-Sieczkowski E, Berger T, Rommer P, Wiest G (2021) Ocular Motor Abnormalities in Anti-IgLON5 Disease Front Immunol, 12
• Zrzavy T, Höftberger R, Wimmer I, Berger T, Rommer P, Macher S (2021) Longitudinal CSF Findings in Autoimmune Encephalitis—A Monocentric Cohort Study Front Immunol, 12
• Zrzavy T, Endmayr V, Bauer J, Macher S, Mossaheb N, Schwaiger C, Ricken G, Winklehner M, Glatter S, Breu M, Wimmer I, Kovacs G, Risser D, Klupp N, Simonitsch‐Klupp I, Roetzer T, Rommer P, Berger T, Gelpi E, Lassmann H, Graus F, Dalmau J, Höftberger R (2021) Neuropathological variability within a spectrum of NMDAR‐encephalitis. Ann Neurol, : 2021 Sep 25. doi: 10.1002/ana.26223. Online ahead of print.
• Zrzavy T, Schwaiger C, Wimmer I, Berger T, Bauer J, Butovsky O, Schwab J, Lassmann H, Höftberger R (2021) Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury Brain, 144(1): 144-161

• Monschein T, Salhofer-Polanyi S, Altmann P, Zrzavy T, Dal-Bianco A, Bsteh G, Rommer P, Berger T, Leutmezer F (2020) Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis J Neurol, 268 (4): 1247-1253
• Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hümmert M, Ringelstein M, Rommer P, Ayzenberg I, Ruprecht K, Klotz L, Asgari N, Zrzavy T, Höftberger R, Tobia R, Buttmann M, Fechner K, Schanda K, Weber M, Asseyer S, Haas J, Lechner C, Kleiter I, Aktas O, Trebst C, Rostasy K, Reindl M, Kümpfel T, Paul F, Wildemann B, (2020) Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients J Neuroinflammation, 17 (1)
• Macher S, Zrzavy T, Höftberger R, Altmann P, Pataraia E, Zimprich F, Berger T, Rommer P (2020) Longitudinal measurement of cerebrospinal fluid neurofilament light in anti‐N‐methyl‐D‐aspartate receptor encephalitis Eur J Neurol, 28 (4): 1401-1405
• Zrzavy T, Wimmer I, Rommer P, Berger T (2020) Immunology of COVID‐19 and disease‐modifying therapies: the good, the bad and the unknown Eur J Neurol,

• Vilariño-Güell C, Zimprich A, Martinelli-Boneschi F, Herculano B, Wang Z, Matesanz F, Urcelay E, Vandenbroeck K, Leyva L, Gris D, Massaad C, Quandt J, Traboulsee A, Encarnacion M, Bernales C, Follett J, Yee I, Criscuoli M, Deutschländer A, Reinthaler E, Zrzavy T, Mascia E, Zauli A, Esposito F, Alcina A, Izquierdo G, Espino-Paisán L, Mena J, Antigüedad A, Urbaneja-Romero P, Ortega-Pinazo J, Song W, Sadovnick A (2019) Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease PLOS Genet, 15 (6): e1008180
• Wimmer I, Scharler C, Zrzavy T, Kadowaki T, Mödlagl V, Rojc K, Tröscher A, Kitic M, Ueda S, Bradl M, Lassmann H (2019) Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune encephalomyelitis Acta Neuropathologica Communications, 7 (1): 14
  | Weblink |
• Zrzavy T, Höftberger R, Berger T, Rauschka H, Butovsky O, Weiner H, Lassmann H (2019) Pro-inflammatory Activation of Microglia in the Brain of Patients with Sepsis Neuropathol Appl Neurobiol, 45(3): 278-290

• Zrzavy T, Kollaritsch H, Rommer P, Boxberger N, Loebermann M, Wimmer I, Winkelmann A, Zettl U (2019) Vaccination in Multiple Sclerosis: Friend or Foe? Front Immunol, 10

• Reinthaler E, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill C, Hoffjan S, Epplen J, Zettl U, Hecker M, Deutschländer A, Meuth S, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick A, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A (2018) TPP2 mutation associated with sterile brain inflammation mimicking MS Neurol Genet, 4 (6): e285
• Zrzavy T, Kovacs-Nagy R, Reinthaler E, Deutschländer A, Schmied C, Kornek B, Leutmezer F, Zimprich A (2018) A rare P2RX7 variant in a Hungarian family with Multiple Sclerosis Mult Scler Relat Disord.,
• Zrzavy T, Machado-Santos J, Christine S, Baumgartner C, Weiner H, Butovsky O, Lassmann H (2018) Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts Brain Pathol, 28(6): 791-805

• Wimmer I, Zrzavy T, Lassmann H (2018) Neuroinflammatory responses in experimental and human stroke lesions J Neuroimmunol, 323: 10-18

• Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O’Loughlin E, Xu Y, Fanek Z, Greco D, Smith S, Tweet G, Humulock Z, Zrzavy T, Conde-Sanroman P, Gacias M, Weng Z, Chen H, Tjon E, Mazaheri F, Hartmann K, Madi A, Ulrich J, Glatzel M, Worthmann A, Heeren J, Budnik B, Lemere C, Ikezu T, Heppner F, Litvak V, Holtzman D, Lassmann H, Weiner H, Ochando J, Haass C, Butovsky O (2017) The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases Immunity, 47 (3): 566-581.e9
• Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner H, Lassmann H (2017) Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis Brain, 140 (7): 1900-1913

• Haider L, Zrzavy T, Hametner S, Höftberger R, Bagnato F, Grabner G, Trattnig S, Pfeifenbring S, Brück W, Lassmann H (2016) The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain Brain, 139 (3): 807-815